This study demonstrated that early SLE onset, arthritis, existing organ damage (SDI≥1) at registration, anti-RNP positivity, and high maximum glucocorticoid daily dose contributed to the development of AVN independently, thus providing information for early risk stratification of AVN in SLE patients. This evidence concerns the gene RNPC3 and systemic lupus erythematosus.